Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Liabilities and Shareholders Equity (2016 - 2025)

Balchem (BCPC) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $1.7 billion as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 4.01% to $1.7 billion in Q3 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 47.64% decrease, with the full-year FY2024 number at $1.6 billion, down 1.37% from a year prior.
  • Liabilities and Shareholders Equity was $1.7 billion for Q3 2025 at Balchem, up from $1.6 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.7 billion in Q3 2025 to a low of $1.2 billion in Q1 2021.
  • A 5-year average of $1.5 billion and a median of $1.6 billion in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 38.47% in 2022, then fell 1.81% in 2023.
  • Balchem's Liabilities and Shareholders Equity stood at $1.2 billion in 2021, then surged by 35.45% to $1.6 billion in 2022, then dropped by 1.68% to $1.6 billion in 2023, then fell by 1.37% to $1.6 billion in 2024, then grew by 5.44% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for BCPC's Liabilities and Shareholders Equity are $1.7 billion (Q3 2025), $1.6 billion (Q4 2024), and $1.6 billion (Q3 2024).